Medscape Medical NewsAll articles

syngo.CT Extended Functionality

Siemens Medical Solutions USA, Inc. • Radiology • 01/20/2022

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

syngo.CT Extended Functionality is a medical imaging software designed to enhance diagnostic capabilities by providing a suite of tools for advanced visualization, quantitative analysis, and specialized clinical evaluation of CT and MR image data. It achieves this through various extensions, including new trauma-focused layouts, improved spectral imaging, and enhanced vascular analysis, all aimed at supporting clinicians in making more informed diagnostic decisions.

Summary

syngo.CT Extended Functionality is a software package designed to augment medical imaging diagnostics by providing advanced visualization and analysis tools for clinicians. It processes clinical data acquired from Computed Tomography (CT) scanners and other modalities like Magnetic Resonance (MR) scanners, enabling technicians and physicians to perform qualitative and quantitative measurements. The software facilitates the creation of advanced visualizations and detailed analyses, ultimately assisting in the preparation and processing of medical images for diagnostic purposes, with the resulting images aiding physicians in their diagnostic workflow. The current version, SOMARIS/8 VB60, introduces a new "Trauma" extension for organizing and displaying reconstruction series by body region and includes significant modifications to existing extensions. The "Interactive Spectral Imaging" extension now supports additional datasets from CT scanners and displays mean ROI values, enhancing dual-energy data representation, while the "Vascular" extension has been updated to handle larger image formats (greater than 512x512 pixels) for improved vascular evaluation. The device's intended performance has been verified through non-clinical functional and integration testing, and its design incorporates risk management principles and adherence to recognized industry standards for medical device software and usability.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Medical Imaging SoftwareComputed Tomography (CT)Advanced VisualizationImage ProcessingQuantitative AnalysisTrauma ImagingSpectral ImagingVascular AnalysisDiagnostic SupportClinical Data Evaluation

Device Metadata

Submission Number
K214019
Company
Siemens Medical Solutions USA, Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the new "Trauma" extension improve workflow efficiency or diagnostic accuracy in emergency settings compared to previous methods?; What specific types of additional datasets can the modified "Interactive Spectral Imaging" extension now accept, and how do these enhance dual-energy analysis capabilities?; With the "Vascular" extension now supporting images larger than 512x512, what impact does this have on the resolution and detail available for assessing complex vascular structures?; Can the AI algorithm in the "Pulmonary Density" extension be customized or trained further by users for specific patient populations or subtle pathologies?; How does the integration of data from multiple modalities (e.g., CT and MR) within syngo.CT Extended Functionality enhance comprehensive diagnostic assessments for conditions that benefit from multimodal imaging?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score30/100
SBOM Evidence✓ Detected in Summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials(software package)
✓ Detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SBOM, ML-BOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
syngo.CT Extended Functionality - Siemens Medical Solutions USA, Inc. | ESL FDA AI Device Intelligence